| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
2 companies
Koppikar Utpal is a Chief Financial Officer at ATRA, with reported holdings spanning 2 companies. Recent filings cover 2 purchases and 24 sales. Those positions are worth an estimated $1.6M at current prices.
Our model assigns Koppikar Utpal a strong insider score of 76/100, based on 16 past trades. Over a 12-month horizon, 93.8% of those trades were profitable, with an average 12-month return of +58.2%.
Koppikar Utpal's largest disclosed position is in ATRA as Chief Financial Officer, worth about $1.5M. The recent filings there lean toward selling, a net 70,821 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 27, 2020 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 1,827 | $9.17 | $16,753.59 | -1.3% | |
| Feb 6, 2020 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Sell | 1,781 | $14.21 | $25,308.01 | -2.4% | |
| Jul 27, 2018 | ATRA Atara Biotherapeutics, Inc. | Chief Financial Officer | Buy | 2,000 | $36.80 | $73,600.00 | +4.4% |